Sign in

CIK 0001347178

  • Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
030491827
Phone
+1 202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
Open-market buys, last 90 days
$38,094
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Duncan Charles Cliff +$38K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-06-10 Chrousos Phaedra Director Grant or award +5,000 15,000
2021-06-10 Chrousos Phaedra Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2021-03-15 Jones Aranthan II Chief Corp. Affairs Officer Option exercise +15,000 $11.32 $170K 111,935
2021-03-15 Jones Aranthan II Chief Corp. Affairs Officer Sale −18,000 $17.72 $319K 93,935
2021-03-15 Jones Aranthan II Chief Corp. Affairs Officer Option exercise · Employee Stock Option (Right to Buy) −15,000 55,000
2021-03-08 Polymeropoulos Mihael Hristos President and CEO Sale −175,000 $18.00 $3.2M 1,221,062
2021-03-05 Williams Timothy SVP & General Counsel Sale −200 $17.88 $4K 92,326
2021-03-05 Williams Timothy SVP & General Counsel Sale −5,400 $17.85 $96K 86,926
2021-03-02 Williams Timothy SVP & General Counsel Sale −7,674 $18.54 $142K 92,526
2021-03-02 Wijkstrom Joakim SVP, Chief Marketing Officer Sale −3,888 $18.45 $72K 78,202
2021-03-02 Polymeropoulos Mihael Hristos President and CEO Sale −15,206 $18.34 $279K 1,396,062
2021-03-02 Moran Kevin Patrick SVP, CFO & Treasurer Sale −6,044 $18.23 $110K 101,426
2021-03-02 Jones Aranthan II Chief Corp. Affairs Officer Sale −3,865 $18.04 $70K 96,935
2021-03-02 Birznieks Gunther SVP, Business Development Sale −16,620 $18.19 $302K 171,708
2021-03-01 Williams Timothy SVP & General Counsel Sale −11,856 $18.60 $221K 100,200
2021-03-01 Polymeropoulos Mihael Hristos President and CEO Sale −7,479 $18.45 $138K 1,411,268
2021-03-01 Moran Kevin Patrick SVP, CFO & Treasurer Sale −3,327 $18.57 $62K 107,470
2021-03-01 Birznieks Gunther SVP, Business Development Sale −3,845 $18.66 $72K 188,328
2021-02-24 Williams Timothy SVP & General Counsel Grant or award +32,700 112,056
2021-02-24 Williams Timothy SVP & General Counsel Grant or award · Employee Stock Option (Right to Buy) +77,500 77,500

Page 11 of 20 · 387 trades